The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial.
 
Hedy L. Kindler
Consulting or Advisory Role - Aldeyra Therapeutics; Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; ERYTECH Pharma; Five Prime Therapeutics; ipsen; Kyowa Hakko Kirin; Merck; Paradox Therapeutics
Research Funding - Aduro Biotech (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Inhibrx (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Polaris (Inst); Roche/Genentech (Inst); Verastem (Inst)
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Amgen; Celgene; ERYTECH Pharma (Inst); Halozyme; Shire; VECT-HORUS
Speakers' Bureau - Celgene; Shire
Travel, Accommodations, Expenses - Halozyme; Ipsen; Lilly; Merck Serono; Shire
 
Michele Reni
Honoraria - Baxalta/Shire
Consulting or Advisory Role - Baxalta/Shire; Celgene; Novartis; Novocure; Pfizer
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene
 
Eric Van Cutsem
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Teresa Macarulla Mercade
Consulting or Advisory Role - Baxalta; Celgene; Genzyme; QED Therapeutics; Roche; Sanofi/Aventis; Shire; Tesaro
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); OncoMed (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; H3 Biomedicine; Merck; Sanofi
 
Michael J. Hall
Research Funding - AstraZeneca; Caris Life Sciences; Foundation Medicine; InVitae; Myriad Genetics
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Foundation Medicine; Myriad Genetics
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics
 
Joon Oh Park
Honoraria - Celgene; Shire
Consulting or Advisory Role - Celgene; Merck Serono; Shire
Research Funding - Celgene
 
Daniel Hochhauser
Stock and Other Ownership Interests - Novartis; Roche
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Celgene
 
Dirk Arnold
Honoraria - Bayer; Merck Serono; Roche/Genentech; SERVIER; TERUMO
Consulting or Advisory Role - Bayer; Biocompatibles; Helsinn Therapeutics; Merck Serono; Roche; Servier; Terumo
Research Funding - Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche/Genentech
 
Do-Youn Oh
Consulting or Advisory Role - ASLAN Pharmaceuticals; AstraZeneca; Bayer; EMD Serono; Genentech/Roche; Merck; Novartis; Taiho Pharmaceutical
Research Funding - Array BioPharma; AstraZeneca; Green Cross; Lilly; Novartis
 
Anke C. Reinacher-Schick
Honoraria - Amgen; Baxalta; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Pfizer; Roche; Sanofi/Aventis; SERVIER; Shire
Consulting or Advisory Role - Amgen; Baxalta; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD; Pfizer; Roche; Sanofi/Aventis; SERVIER
Research Funding - Celgene; Ipsen; Roche; Sanofi/Aventis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen
 
Giampaolo Tortora
Consulting or Advisory Role - Celgene; Merck Serono
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Hana Algül
Honoraria - Celgene; SERVIER
Research Funding - Chugai Pharma (Inst)
Travel, Accommodations, Expenses - Celgene
 
Eileen Mary O'Reilly
Consulting or Advisory Role - 3DMedcare (I); Agios (I); Alignmed (I); Amgen (I); Antengene (I); Aptus Clinical; Aptus Clinical (I); ASLAN Pharmaceuticals (I); Astellas Pharma (I); AstraZeneca (I); Bayer (I); BeiGene (I); BiolineRx; Boston Scientific (I); Bridgebio (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); CARsgen Therapeutics (I); CASI Pharmaceuticals (I); CASI Pharmaceuticals (I); Celgene; Celgene (I); Celsion (I); Cipla (I); CytomX Therapeutics; Daiichi Sankyo (I); Debiopharm Group (I); Delcath Systems (I); Eisai (I); Exelixis (I); Genoscience Pharma (I); Gilead Sciences; Halozyme; Halozyme (I); Hengrui Medicine (I); Inovio Pharmaceuticals (I); Ipsen (I); Janssen; Jazz Pharmaceuticals (I); Kyowa Hakko Kirin (I); LAM Therapeutics (I); Lilly (I); Loxo; Merck (I); Merrimack; Minapharma (I); Newlink Genetics; Novella Clinical (I); Onxeo (I); PCI Biotech (I); Pfizer; Pharmacyclics; Pharmacyte Biotech; Pieris Pharmaceuticals; QED Therapeutics (I); RedHill Biopharma (I); Sanofi; Sanofi (I); Servier (I); Silenseed; Sillajen (I); Sirtex Medical (I); SOBI; Targovax; Tekmira (I); twoXAR; twoXAR (I); VAXIMM; Vicus Therapeutics (I); Yakult Pharmaceutical (I); Yakult Pharmaceutical (I); Yiviva (I)
Research Funding - Acta Biologica (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Mabvax (Inst); OncoQuest (Inst); OncoQuest (Inst); Roche (Inst)
 
David McGuinness
Employment - AstraZeneca
 
Karen Cui
Employment - AstraZeneca
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
 
Katia Schlienger
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Gershon Y. Locker
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Talia Golan
Honoraria - MSD; Rafael Pharmaceuticals
Consulting or Advisory Role - Abbvie; AstraZeneca
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)